baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC DIS.CERT. 06/24 CALL AMG/ DE000HC7C8F8 /

28/05/2024 13:47:08	Chg.-0.0200	Bid28/05/2024	Ask-	Underlying	Strike price	Expiration date	Option type
2.2600EUR	-0.88%	2.2600 Bid Size: 6,000	- Ask Size: -	AMGEN INC. DL-...	180.00 -	19/06/2024	Call

GlobeNewswire 13:30 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

GlobeNewswire 27/05 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...

GlobeNewswire 23/05 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...

GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 22/05 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...

GlobeNewswire 21/05 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update

GlobeNewswire 21/05 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...

GlobeNewswire 21/05 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer

TeleTrader 16/05 FDA approves Amgen's small cell lung cancer drug

GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants

GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

GlobeNewswire 14/05 Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier

GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...

GlobeNewswire 13/05 TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 09/05 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

GlobeNewswire 09/05 argenx Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/05 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...

GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

TeleTrader 08/05 US closes flat to higher with more earnings on the horizon

GlobeNewswire 08/05 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

TeleTrader 03/05 US closes higher after softer-than-expected jobs print

TeleTrader 03/05 Wall Street surges on open as jobs report sparks rate cut hopes

TeleTrader 03/05 Amgen soars 14% on positive weight-loss drug data

TeleTrader 02/05 Amgen Q1 revenue jumps 22% to $7.4 billion

UC DIS.CERT. 06/24 CALL AMG/ DE000HC7C8F8 /

If you wish to receive reply to your feedback, please provide your email address.